bold = Main text
Part, Chapter, Paragraphgrey = Comment text
9006 II, 9. 4. 7 | http://www.healthyageing.nu/upload/pdf/Chapters%20from%20the%
9007 III, 10. 5. 1 | weknow-waternetwork.com/uploads/booklets/05_small_water_
9008 I, 2. 6 | close to 100 for basic and upper-secondary education. For tertiary
9009 III, 10. 4. 5 | causing the illness to an upstream host. Moreover, toxic algal
9010 III, 10. 3. 1 | the ground in areas with uranium-containing soils and rocks. The most
9011 II, 5. 5. 3 | figures (gender, migrants, urbanicity). Hence, detailed data are
9012 III, 10. 5. 2 | seems easier to define “urbanism” and then label as “rural”
9013 II, 5. 5. 3 | eaManceau E, Lucas B, Lemesle M, Urbinelli R, Giroud M (2000): Incidence
9014 II, 6. 3. 6 | haemorrhages: haemolytic uremic syndrome (HUS). HUS is the
9015 III, 10. 2. 1 | Atherosclerosis*~Kidney and ureter~COPD, asthma and other respiratory
9016 II, 9. 3. 1 | functional layers of the urethra – epithelium, connective
9017 IV, 11. 1. 5 | and passed a resolution urging the World Health Organization
9018 III, 10. 2. 4 | 50:1418-1422.~ ~Hoos A, Urist MJ, Stojadinovic A, Mastorides
9019 II, 9. 3. 1 | Randomized Controlled Trial Eur Urol 51: 659-664~ ~Austbury J: (
9020 II, 9. 3. 1 | neurological problems, urological surgical and many prescription
9021 II, 5. 8. 7 | Norbäck D, d'Errico A, Urrutia I, Payo F, Olivieri M, Villani
9022 II, 5. 10. 3 | food - namely skin rash/urticaria, rhinitis, vomiting, diarrhoea,
9023 II, 6. 4. 4 | institutes of the EU, the US-CDC, Canada and other parts
9024 I, 2. 10. 3 | improve accessibility and usability of digital material in a
9025 IV, 11. 3. 1 | that are acknowledged and usable elsewhere, institutions
9026 IV, 11. 6. 2 | cities.~ ~A 1999 World Bank/USAID survey observed that 71%
9027 II, 9. 4. 5 | in January 2003, will be usefule for developing quality assessment
9028 II, 5. 4. 1 | risk factors that can be usefully targeted as indicators of
9029 IV, 12. 10 | the creation of a European user-driven telemedicine via satellite
9030 IV, 12. 10 | implemented all over Europe upon user-request, promoting the added value
9031 II, 5. 5. 3 | Pennell BE, Zaslavsky AM, Ustun TB, Chatterji S; WHO World
9032 III, 10. 4. 2 | migration from nylon kitchen utensils imported from China (European
9033 II, 9. 3. 1 | while cancer of the corpus uteri adds other 40 000. The effect
9034 II, 5. 1. 1 | system disorders~Exposure in utero or during development to
9035 II, 5. 15. 3 | prevalence estimate, which utilises hospital discharge records (
9036 II, 5. 5. 3 | quality of life and patient utilities of Parkinson’s disease. (
9037 III, 10. 4. 2 | consumption data have been utilized.~ ~Two opinions have been
9038 II, 5. 5. 3 | relatively lower rates in Uusimaa in the south. Prevalence
9039 III, 10. 3. 1 | stop the depletion of the UV-protective ozone layer by phasing out
9040 IV, 12. 10 | Universität Darmstadt~Prog T, uve GmbH für Managementberatung
9041 III, 10. 4. 5 | have no legal owner. In Uzbekistan about 18,000 tonnes of banned
9042 II, 4. 3 | enriching humanity. Geneva, WHO: v-129.~ ~
9043 II, 7. 2. 1 | morbidity and mortality (V01-Y98)~ ~ICD-9:~- Chapter 17 on
9044 II, 5. 3. 9 | Ann Oncol 14 (suppl 5):v128-v149.~ ~ESMO (2006): Medical
9045 II, 5. 3. 9 | registry areas. Ann Oncol 14:v28-v40.~ ~Micheli A, Berrino F,
9046 II, 5. 3. 9 | Ann Oncol 14 (suppl 5):v61-v118.~ ~Stewart BW, Kleihues
9047 II, 5. 1. 4 | with the disease while on vacation.~ ~· Driving and possible
9048 II, 5. 6. 6 | and Lindgren B (1996): Vad kostar sjukdomarna? (What
9049 II, 9. 3. 1 | in some women, vaginitis, vaginimus, and dispareunia. Loss of
9050 IV, 11. 6. 4 | tax-funded NHS-style systems. The vaguest definition of benefits can
9051 IV, 11. 6. 5 | 19: 473-91.~ ~Zentner A, Valasco-Garrido M et al., (2005): "Methods
9052 II, 5. 5. 3 | Disorders in Vilnius (www.valgymosutrikimai.lt)~Luxembourg~ ~X~ ~Macedonia~ ~
9053 IV, 11. 6. 4 | clinically relevant areas and validating them among the participating
9054 II, 5. 5. 3 | screening procedures and validations differed considerably in
9055 II, 5. 6. 6 | Cats A, Vandenbroucke JP, Valkenburg HA (1989): Epidemiology
9056 II, 5. 5. 3 | of multiple sclerosis in Valladolid, northern Spain. J Neurol
9057 III, 10. 4. 2 | veterinārais dienests~Latvia~Valstybineë maisto ir veterinarijos
9058 IV, 12. 10 | terveydenhuollon suunnittelusta ja valtionosuuksista?], which was amended in
9059 II, 9. 2. 3 | but though this project is valuably indicating the scale of
9060 IV, 11. 6. 3 | this may result from higher value-added taxes on luxury goods).
9061 IV, 12. 2 | principles include taking a value-driven approach, recognising the
9062 II, 5. 9. 4 | specific elements of PM such as vanadium (V), nickel (Ni), zinc (
9063 II, 5. 6. 6 | van Romunde LK, Cats A, Vandenbroucke JP, Valkenburg HA (1989):
9064 II, 5. 7. 7 | 20.~Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB,
9065 II, 5. 5. 3 | Wilkins; 435–457.~Celius EG, Vandvik B (2001): Multiple sclerosis
9066 II, 5. 5. 3 | Smeets VMJ, van Lierop BAG, Vanhoutvin JPG, et al (2007): Epilepsy
9067 II, 5. 12. 7 | Doffoel M, Boudjema K, Vanlemmens C, Mantion G, Messner M,
9068 II, 5. 5. 3 | M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto
9069 II, 5. 8. 2 | chemicals, gases, fumes or vapours ( J6 ~· interstitial ( J9 ·
9070 III, 10. 2. 1 | Greiner F, Zajkás G, Szórád I, Varga A, Domonkos A, Agoston H,
9071 II, 6. 3. 5 | will be, licensed (against varicella (chickenpox), human papilloma
9072 II, 5. 11. 3 | eczema, pompholyx eczema, varicose eczema, photosensitive eczema
9073 II, 5. 2. 7 | McQueen M, Budaj A, Pais P, Varigo J, Lisheng A (2004): Effect
9074 II, 5. 11. 3 | Riekki R, Turjanmaa K, Varjonen E, Vuorela AM, Patch test
9075 IV, 12. 10 | Solvents in Certain Paints, Varnishes and Vehicle Refinishing
9076 III, 10. 4. 2 | správa~Slovakia~Direktorat za varno hrano~Slovenia~Agencia Española
9077 II, 5. 2. 7 | Dis 18: S1-16.~Puska P, Vartiainen E, Tuomilehto J, Salomaa
9078 II, 9. 3. 1 | ischemic conditions in the vasculature (White and Holmes, 2006).~ ~
9079 II, 5. 11. 3 | vascular diseases, systemic vasculitides – are regularly associated
9080 IV, 12. 4 | Kyprianou in 2004 and Androulla Vassiliou in 2008. Most health activities
9081 IV, 12. 10 | Physical activity~ Intermediate~ Low VAT for health clubs~ National
9082 II, 5. 5. 3 | Juckel G, Morrirson A, Vázquèz-Barquero JL, Hambrecht M, VON Reventlow
9083 II, 5. 6. 6 | Liang MH, Pillemer SR, Steen VD, Wolfe F (1998): Estimates
9084 II, 5. 6. 6 | Chaussade S, Cucinotta D, Veale DJ, Martin-Mola E (2004):
9085 II, 5. 7. 7 | Pontoriero G, Pozzoni P, Vecchio LD, Locatelli F (2007):
9086 III, 10. 4. 2 | al., 2001;~Fiolet & van Veen, 2001~ ~ ~ ~ ~Pesticides
9087 II, 5. 5. 3 | 345.~Bermejo F, Gabriel R, Vega S, Morales JM, Rocca WA,
9088 III, 10. 2. 1 | of adolescents practise a vegetarian nutrition but many do not
9089 I, 2. 9 | to substantial shifts in vegetation distribution. Changes in
9090 IV, 13. 7 | cartilage, tendons, arteries, veins, heart-valves, cornea, skin,
9091 II, 5. 5. 3 | Benito-Léon J, Martín E, Vela L et al (1998): Multiple
9092 IV, 11. 6. 5 | 213.~ ~Busse R, Orvain J, Velasco M, Perleth M, Drummond M,
9093 III, 10. 3. 4 | of Targovishte, Rousse, Velico Tarnovo, Stara Zagora, Haskovo,
9094 III, 10. 2. 1 | 1156.~ ~Pudule I, Jēce I, Velika B, Grīnberga D, Villeruša
9095 II, 5. 11. 7 | Danish Population. Acta Der Venereo 1992;72:456-60.~ ~Plesko
9096 II, 5. 15. 3 | Piedmont, Lombardy, Tuscany, Veneto) have implemented population-based
9097 I, 2. 7 | in collaboration with the Venice Biennale Foundation, was
9098 II, 5. 11. 3 | angio-edema, bee and wasp venom allergy, drug rashes such
9099 III, 10. 4. 1 | mites, moulds and bacteria. Ventilation-related humidity problems arise
9100 III, 10. 5. 1 | faulty equipment or lack of venting, these pollutants can accumulate
9101 IV, 13. 7. 2 | behind in other key areas. Venture capital investments in the
9102 III, 10. 5. 1 | booklets/05_small_water_systems_ver_june2005.pdf, accessed18
9103 IV, 12. 10 | Aktionsplan 2008/2009 zur Verbesserung der Arzneimitteltherapiesicherheit,
9104 III, 10. 3. 2 | und andere zinnorganische Verbindungen in Lebensmitteln und verbraucher
9105 III, 10. 3. 2 | Verbindungen in Lebensmitteln und verbraucher nachen Produkten.~ ~European
9106 IV, 12. 10 | Consumer Organisations (Verbraucherzentrale Bundesverband, VZBV, see www. -
9107 II, 8. 2. 1 | Tasse, M.J., Thompson, J.R., Verdugo, M-A, Wehmeyer, M.L. and
9108 II, 5. 12. 7 | Sanchez-Hernandez E, Rivero M, Vergara M, Martin -~ ~Ioannou G,
9109 II, 5. 5. 3 | schizophrene Psychosen. Eine vergleichende Langzeitstudie. Springer
9110 II, 5. 5. 3 | W, Boter H, Davidson M, Vergouwe Y, Keet IPM, Gheorghe MD,
9111 II, 5. 7. 7 | 92):S7-10.~Gansevoort RT, Verhave JC, Hillege HL, Burgerhof
9112 II, 9. 4. 7 | 11.07.07]~De Groot Lc., Verheijden Mw., De Henauw S., Schroll
9113 III, 10. 4. 2 | controls such as inspections, verifications, audits, sampling and testing
9114 III, 10. 5. 1 | point seems to be widely verified also in non-European contexts:
9115 IV, 12. 10 | Bundesministerium für ür Verkehr, Bau und Stadtentwicklung,
9116 II, 5. 9. 4 | Turin~Low~–~–~ ~–~High~–~ Verona~Low~Low~–~–~–~–~High~–~High~–~
9117 III, 10. 2. 1 | Storm H, Tubiana M, Tursz T, Veronesi U, Wald N, Weber W, Zaridze
9118 II, 5. 6. 6 | Nationale Studie Naar Ziekten en Verrichtingen in de Huisartspraktijk.
9119 III, 10. 3. 2 | von Platingruppenelementen verschiedener Emittenten in Oberflächengewässer
9120 II, 5. 5. 3 | death in Parkinson disease. Versicherungsmedizin / herausgegeben von Verband
9121 III, 10. 2. 1 | 2005): Latvijas iedzïvotäju veselïbu ietekmëjošo paradumu pëtïjums,
9122 II, 5. 11. 3 | redness, scaling, fissuring, vesicles, and lichenification. In
9123 II, 5. 8. 7 | Scharling H, Fabricius P, Vestbo J (2006): Developing COPD:
9124 II, 5. 5. 3 | pattern was reported for Vestfold and for Hordaland County.
9125 III, 10. 4. 2 | Veterinaerinstituttet~Denmark~Veterinaar-ja Toiduamet~Estonia~Elintarviketurvallisuusvirasto
9126 III, 10. 4. 2 | Cyprus~Fødevarinstituttet Veterinaerinstituttet~Denmark~Veterinaar-ja Toiduamet~
9127 III, 10. 4. 2 | Salute~Italy~Pārtikas un veterinārais dienests~Latvia~Valstybineë
9128 III, 10. 4. 2 | Latvia~Valstybineë maisto ir veterinarijos tarnyba~Lithuania~Sécurité
9129 III, 10. 4. 2 | Alimentelor~Romania~Štátna veterinárna a potravinová správa~Slovakia~
9130 III, 10. 3. 2 | gesundheitlichen Verbraucherschutz und Vetrinärmedizin (BgVV) (2000): Triutylzinn (
9131 II, 5. 11. 3 | consequences of atopic dermatitis vexes its bearers not only by
9132 IV, 11. 5. 4 | order to preserve organ viability). In addition, for organs
9133 III, 10. 2. 1 | toothpaste and mouthwash, vibrating floss and on-the-go mouth-freshening
9134 III, 10. 5. 3 | prevention of risks arising from vibration~ ~Work-related skin /eye /
9135 III, 10. 4. 2 | tuberculosis other than in point A, vibriosis and yersiniosis;~• parasitic
9136 II, 9. 3. 1 | strategies relating to CHD: A video-simulation experiment. Social Science &
9137 IV, 12. 10 | determinants and settings~ ~ www.vidm.gov.lv~ National Environmental
9138 III, 10. 2. 1 | dos Santos O, Camolas J, Vieira J, Carreira M, Medina L,
9139 II, 5. 8. 7 | Jimenez-Ruiz CA, Fernandez-Fau L, Viejo JL, Miravitlles M. (2004):
9140 III, 10. 2. 1 | e.pdf).~ ~Visscher TLS, Viet LA, Kroesbergen HT, Seidell
9141 II, 5. 5. 3 | at: http:www.medscape.com/viewarticle/457027.~Suvisaari JM, Haukka
9142 II, 5. 5. 3 | Sperry S, Thompson JK (2008): Viewership of Pro-Eating Disorder Websites:
9143 IV, 12. 10 | reflect a shift away from viewing health in terms of illness
9144 II, 5. 7. 7 | McKenna AM, Keating LE, Vigneux A, Stevens S, Williams A,
9145 III, 10. 2. 1(20)| or 1,500 MET minutes of vigorous-intensity activity accumulated over
9146 II, 9. 3. 3 | et Comportements Face au VIH/sida en Ile de France –
9147 III, 10. 2. 5 | Brubakk AM, Romundstad P, Vik T (2007): Prenatal smoking
9148 IV, 12. 10 | beslutning om, hvordan de vil arbejde med sundhedsfremme.~ ~ ~
9149 I, 2. 10. 3 | perspective of earth as a “common village” is becoming more and more
9150 I, 2. 7 | designed around a series of village-style neighbourhoods to make it
9151 II, 5. 8. 7 | Urrutia I, Payo F, Olivieri M, Villani S, Van Sprundel M, Antó
9152 II, 5. 8. 7 | Masa JF, Sobradillo V, Villasante C, Jimenez-Ruiz CA, Fernandez-Fau
9153 II, 7. 7 | Eriksson L, Tingvall C, Villaveces A (2004): Preventing Road
9154 III, 10. 2. 1 | Velika B, Grīnberga D, Villeruša A, Dzērve V, Zīle S, Helasoja
9155 III, 10. 2. 1 | Kroke A, Bamia C, Karalis D, Vineis P, Palli D, Bueno-de-Mesquita
9156 I, 2. 3 | human rights that might be violated by it, should not be underestimated.~ ~
9157 IV, 12. 10 | system penalties for the violation of the regulations.~o TV
9158 II, 8. 2. 1 | exposed to human rights violations and deprived of minimum
9159 II, 9. 5. 1 | work-related accidents) and violence-related mortality in men seem to
9160 II, 7.Acr | VRU~Vulnerable Road Users~VIP~Violence and Injury prevention~
9161 IV, 12. 10 | Arbejdsmiljøcertifikat (2001): Virksomheder, der ønsker et arbejdsmiljøcertifikat
9162 IV, 13. 7. 3 | cardiovascular medicine, virology, and brain & behaviour,
9163 IV, 12. 1 | activities deemed necessary by virtue of other chapters of this
9164 III, 10. 4. 2 | the serotypes and other virulence factors related to human
9165 II, 6. 3. 7 | VHF in general, some on virus-specific infections, while others
9166 IV, 11. 1. 5 | approaches such as peer review/visitation, clinical audit, quality
9167 IV, 12. 8 | each country as well as visitor programmes using specific
9168 III, 10. 2. 1 | impairment of attention and visuospatial skills.~ ~It has been estimated
9169 II, 5. 12. 7 | benefits and risks. Int J Vitam Nutr Res 71:210-213.~ ~Leon
9170 III, 10. 3. 1 | Milieumaatschappij, MIRA, MIRA/2003/02, Vito. Downloadable from: htt /ME
9171 -, 1 | management of the project.~ ~ Vittorio Silano Luciano Vittozzi~
9172 -, 1 | Vittorio Silano Luciano Vittozzi~Project Coordinator Project
9173 III, 10. 2. 5 | Dragonas T, Paradisiotou A, Vizakou S, Roberts R, Cox A, Day
9174 III, 10. 2. 1 | Kéki Z (2005): Táplálkozási vizsgálat Magyarországon, 2003-2004 [
9175 II, 5. 7. 7 | donoghue DJ, de LS, Van VJ, Klebe B, Middleton R, et
9176 III, 10. 3. 1 | uitgevoerd in opdracht van de Vlaamse Milieumaatschappij, MIRA,
9177 II, 5. 5. 3 | Ooteghem P, De Hooghe MB, Vlietnick R, Carton H (1994): Prevalence
9178 II, 5. 5. 3 | Med 338:1715-1722.~Smeets VMJ, van Lierop BAG, Vanhoutvin
9179 III, 10. 3. 2 | Programme~US~United States~VOC~Volatile organic chemicals~
9180 III, 10. 4. 1 | 5 ), NH3 , NOx, SO2 and VOCs and their reaction products (
9181 III, 10. 4. 2 | Livsmedelsverket~Sweden~Voedsel en Waren Autoriteit~The
9182 II, 5. 5. 3 | Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky
9183 II, 5. 6. 6 | Ensrud KE, Cauley J, Black D, Vogt TM (1995): Risk factors
9184 II, 5. 8. 7 | Huchon G, Huas D, Godard P, Voinet C, Chanal I, Jourdanne C,
9185 II, 5. 3. 2 | oxfordjournals.org/content/vol18/suppl_3/index.dtl.~ ~ ~ ~
9186 III, 10. 2. 1 | Individual dietary record~7~Volatier J.L. Enquête INCA Individuelle
9187 III, 10. 4. 5 | as: solubility, mobility, volatility, sorption capacity, persistence
9188 III, 10. 1. 1 | cognitive factors such as volitional control towards exercise,
9189 II, 7. 4. 4 | ball games such as soccer, volleyball, handball and basketball (
9190 II, 5. 5. 3 | Higginson I, Pitschnau-Michel D, Voltz D (2006) Position Paper
9191 II, 5. 11. 3 | S Lisby, O Baadsgaard, A Vølund, T Menné, Decrease in nickel
9192 II, 9. 3. 3 | N, Lagarde M, Wu Zhou X, Vongmany N, Gremy I (2005) Les Connaissances,
9193 I, 2. 10. 4(11)| effect van elektronisch voorschrijven en electroninische toedienregistratie
9194 IV, 12. 10 | zivilrechtlichen Schutz vor Gewalttaten und Nachstellungen,
9195 III, 10. 2. 4 | Lunshof JE, Chadwik R, Vorhaus DB, Church GM (2008): From
9196 IV, 12. 10 | Proportion of young first-time voters (general elections)~ ~Domain
9197 II, 7.Acr | Standardised Death Rate~VRU~Vulnerable Road Users~VIP~
9198 II, 7. 4. 3 | 300 vulnerable road users (VRUs: pedestrians, cyclists and
9199 III, 10. 4. 2 | the databases to identify vulnerabilities due to eating habits. High
9200 III, 10. 4. 2 | wound infection~ ~High (V. vulnificus),~ ~ ~ ~Medium (other)~Yersinia
9201 II, 9. 3. 1 | population-based study of vulvar cancer. J Natl Cancer Inst,
9202 II, 5. 11. 3 | Turjanmaa K, Varjonen E, Vuorela AM, Patch test reactions
9203 II, 9. 5. 6 | Lindholm G (1995): ÎSkolgrden, -vuxnas bilder -barns miljñÌ~ ~Michels
9204 III, 10. 4. 2 | cereals.~ ~Monitoring by VWA~and food industry~ ~Pieters
9205 III, 10. 2. 1 | Antropometrické ukazovatele a ich využitie na sledovanie trendov telesného
9206 III, 10. 2. 1 | sledovanie trendov telesného vývinu detí a mládeže [Anthropometric
9207 III, 10. 2. 1 | Authority (2004): Telesný vývoj detí a mládeže v Slovenskej
9208 IV, 12. 10 | Verbraucherzentrale Bundesverband, VZBV, see www. - umbrella organization
9209 III, 10. 1. 3 | Eliakim A, Brasel JA, Lee W-NP, Burke G, Cooper DM (1998):
9210 II, 9. 3. 1 | Internal Medicine 148(9): 680-W137.~ ~Shah, J., (2002) Erectile
9211 IV, 11. 6. 5 | Jan-Jun(Suppl Web Exclusives): W5-97-W5-107.~ ~Taggiasco Nì, Sarrut
9212 III, 10. 3. 1 | Estimation. Umweltbundesambt. WaBoLu Hefte 01/06. [On-line publication
9213 II, 5. 4. 8 | Gfrerer, R, Trajanoski, Z, Wach, P, and Pieber, T. (2001)
9214 III, 10. 2. 4 | Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng
9215 III, 10. 4. 2 | Monitoring; autumn~2002 Wadden Sea~fishing grounds~temporarily
9216 II, 9. 4. 7 | Jaleel H, Allan P S, Wade A A (1999): Sexually transmitted
9217 II, 9. 3. 3 | STD&AIDS 15:56-60~Bajos N, Wadsworth J, Ducot B, Johnson AM,
9218 II, 5. 5. 3 | Sudden death in epilepsy: a wake-up call for management. Lancet
9219 II, 5. 10. 7 | Kowalski M, Papadopoulos NG, Wal JM, Clare Mills EN, Vieths
9220 II, 9. 5. 6 | pdf~ ~Women’s Aid (citing Walby & Allen) (2004):~ht 07 Available
9221 III, 10. 2. 1 | European Commission (2000b): WalCyng: How to enhance WALking
9222 III, 10. 2. 1 | M, Tursz T, Veronesi U, Wald N, Weber W, Zaridze DG,
9223 III, 10. 5. 1 | by children (1257-RP).~ ~Walinder R, Gunnarsson K, Runeson
9224 III, 10. 5. 1 | stress reactions in pupils (Wålinder et al, 2007).~ ~Therefore,
9225 III, 10. 5. 1 | areas: the importance of walkable green spaces. In: Journal
9226 III, 10. 6. 1 | 15 year old girls in the Walloon region report easy communication
9227 III, 10. 2. 1 | Navarro C, Martinez GC, Wallstrom P, Zhang JX, Welch AA, Spencer
9228 II, 5. 10. 2 | crayfish), tree nuts (almonds, walnuts, hazelnuts, Brazil nuts
9229 II, 5. 6. 6 | Sisitsky T, Auerbach R, Wanke LA, Buatti MC (2000): Direct
9230 II, 5. 11. 7 | Weismann K, Krakauer R, Wanscher B (1980): Prevalence of
9231 IV, 11. 1. 3 | resources are used to attain wanted outcomes – and, ultimately,
9232 III, 10. 2. 4 | Lehmann DJ, Cortina-Borja M, Warden DR, Smith D, Sleegens K,
9233 III, 10. 2. 1 | Moody A, Stamatakis E, Wardle H (2005): Obesity among
9234 III, 10. 4. 2 | Livsmedelsverket~Sweden~Voedsel en Waren Autoriteit~The Netherlands~
9235 IV, 12. 10 | product testing (Stiftung Warentest, see www. – independent
9236 II, 6. 3. 7 | recorded as a biological warfare agent since 1941.~ ~Over
9237 II, 6. 3. 7 | and it occurs worldwide in warm-blooded mammals. The transmission
9238 I, 2. 9 | for land alone. Europe has warmed more than the global average (
9239 III, 10. 3. 4 | have accelerated. The 10 warmest years on record occurred
9240 I, 2. 9 | than the global average.~ ~Warming of surface water can have
9241 II, 5. 5. 3 | aggressive treatment is warranted in all patients with MS
9242 II, 9. 5. 1 | prepare men to fight in wars or to work in hazardous
9243 IV, 12. 10 | public to report failures~to wash hands~ ~Publication of annual
9244 II, 6. 3. 6 | cats or from inadequately washed contaminated fruits or vegetables,
9245 II, 5. 11. 3 | and angio-edema, bee and wasp venom allergy, drug rashes
9246 III, 10. 3. 2 | Zischka, C Pettersson, U Wass, M Luna, JC Saenz, J Santamaria (
9247 II, 9. 3. 1 | 14: 256-262~ ~Braun, M., Wassner, G Klotz, T Reifenrath,
9248 III, 10. 4. 5 | and effect, and compare waste-related exposures with those due
9249 II, 9. 5. 4 | Framework Programme (FP5) Gender Watch System, to examine earlier
9250 IV, 13. 8 | In addition, NGOs act as watchdogs. However, NG0s benefit from
9251 IV, 12. 10 | use like snuff or shisha/waterpipe are also addressed.~Increases
9252 III, 10. 4. 1 | M.,Hurley, F., Pye S., Watkiss P. and Hunt A. (2007) improving
9253 II, 5. 4. 6 | already present.~According to Waugh et al (2007), the scope
9254 III, 10. 3. 1 | filters most of the shorter wavelength UV-B and the UV-C, but the
9255 II, 7. 7 | Schopper D, Lormand JD, Waxweiler R (Eds.) (2006): Developing
9256 III, 10. 4. 5 | Switzerland and Liechtenstein)~WCE~Western and Central Europe~
9257 III, 10. 2. 1 | Education.~ ~Brettschneider WD, Naul R (2004): Study on
9258 II, 5. 5. 1 | disease as Work Days Lost (WDL).~ ~About one in three or
9259 II, 5. 4. 6 | Screening may be an important weapon in the secondary prevention
9260 II, 6. 3. 2 | one of its most important weapons against infectious diseases.~ ~
9261 IV, 12. 10 | obesity, BzGA provides a web-site focusing on eating disorders (www e)
9262 IV, 12. 10 | non-smoking activities such as web-sites and internet-platforms for
9263 III, 10. 4. 2 | including its corporate website, webcasting, participation in events
9264 II, 5. 6. 6 | Badley EM, Rasooly I, Webster GK (1994) Relative importance
9265 III, 10. 4. 2 | recommendations on the "Weeds to revise the Community
9266 II, 5. 4. 8 | Armesto SG, Lapetra ML, Wei L, Kelley E and the Members
9267 III, 10. 2. 1 | German): ht ~ ~Elmadfa I, Weichselbaum E (eds) (2005): European
9268 III, 10. 4. 2 | quantitative one) to compare/weigh the potential risk against
9269 IV, 11. 1. 5 | services. Each indicator is weighed, contributing to an overall
9270 II, 9. 2. 3 | underweight and to engage in weight-gaining and muscle-enhancing activities (
9271 IV, 11. 6. 4 | established based on crude weightings of age and sex. More sophisticated
9272 III, 10. 2. 1 | Fernandez Feito A, Mattisson I, Weinehall L, Riboli E, Slimani N (
9273 II, 5. 10. 7 | Abramson M, Raven JM, Bailey M, Weiner JM, Walters EH et al (1998):
9274 II, 5. 5. 3 | ahead of print].~Gaebel W, Weinmann S, Sartorius N, Rutz W,
9275 II, 5. 5. 3 | Lucchinetti C, Rodriguez M, Weinshenker BG (2000): Multiple sclerosis.
9276 III, 10. 2. 1 | Sekula W., Nelson M., Weisell R.C.: The Household Food
9277 III, 10. 5. 1 | Knowledge Network on Water WEKNOW, 2005 (http://www. weknow-waternetwork.
9278 III, 10. 5. 1 | WEKNOW, 2005 (http://www. weknow-waternetwork.com/uploads/booklets/05_
9279 II, 5. 7. 7 | EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, et al (2003):
9280 II, 9. 2. 3 | world where there has been a welcomed reduction in infectious
9281 IV, 13. 8 | European Commission, 2001) In welcoming the expanding role and diversity
9282 III, 10. 3. 4 | as populations are less well-adapted to cold . However, cold
9283 III, 10. 4. 2 | Human Health. During this well-attended international meeting, an
9284 II, 5. 5. 3 | but due to a paucity of well-controlled randomized studies, a final
9285 II, 6. 4. 1 | are greatly facilitated by well-functioning surveillance systems. Surveillance
9286 IV, 11. 1. 1 | their own context based on well-informed comparative research. The
9287 II, 8. 2. 2 | integrated into well managed, well-monitored national health systems.~ ~
9288 II, 5. 5. 3 | adolescents to have a normal and well-ordered life and development.~The
9289 II, 5. 2. 4 | Project is an example of well-recognised approach to community-based
9290 IV, 13. 6. 2 | physician is generically well-understood, but there is no common
9291 II, 9. 3. 3 | Herlitz et al, 2005), Britain (Wellingset al, 2001), UK (Johnson et
9292 III, 10. 4. 3 | water and groundwater as welll as of water quantity and
9293 II, 5. 2. 4 | a reduced CVD incidence (Wellman J, 2004).~Due to differences
9294 III, 10. 2. 1 | McNamara H, Joseph KS, Wen SW (2002): Why are babies
9295 II, 8. 2. 1 | 32% (Rantakallio and von Wendt, 1986). Prevalence of severe
9296 II, 5. 2. 6 | 46: 1855-1862.~Stamler J, Wentworth D, Neaton JD (1986). Is
9297 II, 5. 5. 3 | Mackeprang T, Hansson L, Werdelin G, Karlsson H, Bjarnason
9298 II, 5. 8. 7 | Wagena E, Akkermans RP, Wesseling GJ (2002): Detecting patients
9299 I, 2. 10. 4(11)| toedienfouten”, Elsbeth Wesselink, Gerle Ziekenhuizen, 10
9300 III, 10. 5. 1 | comparative EU-funded study in west-Europe found low ventilation rate
9301 II, 5. 5. 3 | 343-350.~Callenbach PM, Westendorp RG, Geertz AT, et al (2001):
9302 II, 5. 5. 3 | 3:35-36.~Shackleton DP, Westerndorp RGJ, Kastelejin-Nolst Trenite
9303 II, 6. 3. 4 | Industrialised countries with Westernised economies where TB rates
9304 III, 10. 3. 2 | Lancet 368, 2167-2178.~ ~Westfälisches Institut für Wasserforschung (
9305 I, 2. 10. 4(12)| Celsea an Westmenister Healthcare NHS Trust, K.
9306 I, 2. 10. 4 | to 0.84%)11. Chelsea and Westminster Healthcare NHS Trust, UK,
9307 II, 9. 3. 3 | Prevention.~Shepherd J, Weston R, Peersman G, Napuli IZ,
9308 III, 10. 6. 1 | Kessler R, McLeod J, Wethington E. The cost of caring: a
9309 III, 10. 4. 2 | in soil organisms), ( 2 WGs are working in parallel).~ ~
9310 II, 5. 5.Int(13)| int/gb/archive/pdf_files/WHA55/ea5518.pdf]~
9311 III, 10. 2. 1 | Health Assembly resolution WHA57.17 on a global strategy
9312 II, 9. 5. 4 | harmful use of alcohol (WHA58.26[53]) of 2005, which recognizes
9313 III, 10. 3. 2 | predators, such as seals, whales, dolphins and polar bears
9314 II, 5. 5. 3 | to patients restricted to wheelchairs, confined to bed and totally
9315 II, 5. 7. 7 | 44.~Baigent C, Burbury K, Wheeler D (2000): Premature cardiovascular
9316 | whence
9317 | wherein
9318 II, 7. 4. 3 | road users were injured whereof 1.3 million were bicyclists.
9319 II, 5. 10. 5 | from soybean sources.~ ~(d) whey used for making distillates
9320 II, 5. 14. 3 | 1.1 DMFT, France at 1.1, whilethe corresponding figure for
9321 III, 10. 2. 4 | S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B,
9322 IV, 12. 10 | act as input to a national white-paper expected in 2009/10.~ ~The
9323 II, 5. 6. 6 | psychiatric illness: the Whitehall II Study. Soc Sci Med 40:
9324 III, 10. 2. 1 | toothbrushes, toothpaste and tooth whiteners. Toothpaste constitutes
9325 III, 10. 3. 1 | Tirmarche M, Tomáek L, Whitley E, Wichmann HE, Doll R, (
9326 II, 5. 2. 6 | 1159-1166.~Lewington S, Whitlock G, Clarke R, Sherliker P,
9327 III, 10. 3. 2 | for long-range transport, whlile acrylamide is given as an
9328 III, 10. 1. 3 | Melzer K, Kayser B, Saris WHM, Pichard C (2005): Effects
9329 II, 5. 5. 3 | misallocation of resources~The WHO-Atlas on Mental Health delivers
9330 III, 10. 4. 3 | variations. Further, data for the WHO-European Region show that coverage
9331 II, 5. 5. 1 | some discrepancies between WHO-HFO and EUROSTAT due to different
9332 II, 5. 5. 3 | gap as demonstrated in the WHO-initiated World Mental Health Surveys (
9333 IV, 12. 10 | for general population (WHO-initiative “Quit & Win”, see www.rauchfrei2008.
9334 IV, 11. 3. 1 | through agencies such as the WHO-sponsored World Federation for Medical
9335 III, 10. 4. 2 | weekly intake (TWI) of 14 pg WHO-TEQ/kg body weight for dioxins
9336 III, 10. 2. 1 | obesity. Macroeconomic and whole-of-government interventions (e.g. taxation
9337 III, 10. 2. 1 | obesity in schools where the whole-school approach is adopted. Studies
9338 III, 10. 2. 1 | fruit and vegetables and wholemeal products.~ ~Table 10.2.1.
9339 IV, 11. 6. 2 | CEE countries is almost wholly driven by an increase in
9340 II, 9. 5. 6 | Geneva. Available at: http://whqlibdoc.who.int/hq/2000/who_msd_
9341 IV, 13. 9 | http://www.who.int/entity/whr/2003/en/whr03_en.pdf]~ ~
9342 IV, 13. 9 | who.int/entity/whr/2003/en/whr03_en.pdf]~ ~WHO (2005): The
9343 II, 5. 5. 3 | Pathol 6:259-274.~Mc Donald WI, Compston A, Edan G, et
9344 II, 5. 5. 3 | Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C,
9345 II, 5. 9. 7 | EA, Custis N, Ronmark E, Wickens K, Sporik R, Woodfolk JA,
9346 II, 5. 3. 8 | European Union can promote a wide-range debate to find ways of reducing
9347 III, 10. 4. 2 | set-up to facilitate and widen the dissemination of animal
9348 II, 9. 2. 3 | than boys. The gender gap widens with age (Fig. 2). On average,
9349 II, 5. 5. 3 | Isacson D, Bingefors K, Widerlöv B (2007): Mortality among
9350 II, 5. 5. 3 | Gilbert CC, Bergman P, Widhalm K, Manios Y, Breidenasse
9351 II, 9. 4. 3 | divorced, separated or widow/widowers. Their single status often
9352 II, 5. 7. 7 | 21(8):2178-83.~Tonelli M, Wiebe N, Culleton B, House A,
9353 II, 5. 5. 3 | drug-induced changes in metabolism. Wien Klin Wochenschr 118 (7-8):
9354 II, 5. 5. 3 | 338:278-285.~Trisolini M, Wiener J, Miller D (2002): Principles
9355 III, 10. 2. 4 | Cox N J, Wichmann H E, Wienker T F, Schulze J, Schwarz
9356 III, 10. 2. 1 | of the population 2005]. Wiesbaden, Federal Statistical Office (
9357 II, 9. 1. 2 | S, Physick N, Tenconi R, Wiesel A, Calzolari E, Stone D (
9358 II, 5. 10. 7 | E, Mothes T, Troncone R, Wieser H (2001): Analysis and clinical
9359 III, 10. 2. 1 | 61:743-751.~ ~Paccaud F, Wietlisbach V, Rickenbach M (2001):
9360 II, 5. 5. 3 | study made on the Isle of Wight found children with epilepsy
9361 II, 5. 6. 6 | 42(4):516-21~Kallman DA, Wigley FM, Scott WW, Jr., Hochberg
9362 III, 10. 4. 2 | but severe consequences~ ~Wildilife~Source: EFSA~ ~ ~Table 10.
9363 II, 9. 3. 1 | accessed 07.07)~ ~Brownhill S, Wilhelm K, Barclay L & Schmied V (
9364 II, 5. 3. 9 | 94:606-616.~ ~Jonsson B, Wilking N (2007): Summary. Ann Onc
9365 II, 5. 5. 3 | Reid WG, O’Sullivan DJ, Williamson PM (1999): The sydney multicentre
9366 II, 9. 5. 6 | caregiving. (Edited by: Willson K). Aurora, Ontario: Garamond
9367 IV, 12. 10 | WHO-initiative “Quit & Win”, see www.rauchfrei2008.
9368 III, 10. 2. 1 | synergies involved create a win-win situation for all actors.
9369 III, 10. 5. 1 | building, mostly through open windows but – in the case of noise –
9370 III, 10. 4. 5 | spray is inhaled during windy days.~ ~“Swimmers Itch”
9371 II, 9. 3. 3 | Bernhardt JM, Burgess-Whitman N, Wingood GM (2005): Adolescents’
9372 II, 5. 7. 3 | marred with difficulties (Winkelmayer et al, 2005). No data has
9373 III, 10. 3. 4 | Commission’s Communication "Winning the Battle against Global
9374 III, 10. 4. 2 | fire~ retardants 2003~ ~De Winter-Sorkina et al.,~2003~ ~ ~Community
9375 III, 10. 2. 1 | and carbohydrate sources (Wirfalt et al, 2002) have been described
9376 II, 5. 5. 3 | Ergebnisse von Metaanalysen zur Wirksamkeit. Psychiat Prax 34(1):S28-S32.~
9377 II, 9. 5. 6 | Schneekloth U, Müller U (2000): Wirkungen der Plfegeversicherung.
9378 IV, 11. 5. 4 | and to communicate their wishes to their relatives. Only
9379 III, 10. 2. 1 | powerful deterrent for parents wishing to allow their children
9380 II, 9. 2. 7 | accessed 12.01.07)~ ~Ståhl T, Wismar M, Ollila E, Lahtinen E,
9381 III, 10. 4. 2 | third country, to refuse, withdraw or modify authorisations
9382 III, 10. 2. 1 | quit smoking should not be withheld a less hazardous form of
9383 III, 10. 2. 1 | reducing the variance of within-subject variations due to random
9384 III, 10. 2. 1 | M, Stokes E, Sumnall H, Witty K, Bellis M (2007): A review
9385 III, 10. 2. 1 | Neukirch F, Vermeire P, Wjst M and Burney P (2006): Changes
9386 III, 10. 2. 1 | Monteiro CA, Moura EC, Conde WL, Popkin BM (2004): Socioeconomic
9387 II, 5. 5. 3 | in metabolism. Wien Klin Wochenschr 118 (7-8):196-206.~European
9388 III, 10. 2. 4 | Zika E, Papatryfon I, Wolf O, Gómez-Barbero M, Stein
9389 II, 5. 11. 3 | IM Freedberg, AZ Eisen, K Wolff, KF Austen, LA Goldsmith,
9390 II, 9. 2. 6 | the child begins in the womb, hence parental nutrition,
9391 III, 10. 2. 1 | literature. Journal of Midwifery Womens Health 48:338–345.~ ~European
9392 II, 5. 9. 7 | E, Wickens K, Sporik R, Woodfolk JA, Platts-Mills TA (2005):
9393 II, 5. 5. 3 | 52.~Carney CP, Jones L, Woolson RF (2006): Medical comorbidity
9394 III, 10. 2. 1 | is measured while data on work-, transport- or domestic-related
9395 IV, 13. 4 | Member States facing such work-force shortages, adequate recruitment,
9396 I, 2. 4 | they live in jobless or low work-intensity households or because their
9397 III, 10. 1. 1 | stigmatized when participating in work-out classes in which the great
9398 Key, Ap5. 0. 0 | workers~workforce~working~work-place~wound~wrist~
9399 III, 10. 5. 3 | 391 (Framework), 89/654 (Work-places), 89/655 (Work Equipment),
9400 III, 10. 5. 3 | career and promoting the workability of ageing workers.~ ~New
9401 II, 5. 9. 3 | health resources and loss of workdays. For a better evaluation
9402 I, 2. 10. 3 | allow for the development of worker-centric, flexible, scalable and
9403 II, 5. 4. 2 | their families, friends and workmates:~ ~-> Management of their
9404 III, 10. 2. 1 | and obesity in school and worksite settings: a report on recommendations
9405 IV, 12. 10 | nutrition and ergonomics at the workstation~www. de Prevention at the
9406 III, 10. 5. 3 | layout of workplaces and workstations~- information, instruction
9407 II, 9. 3. 1 | A complete diagnostic workup is mandatory before taking
9408 II, 5. 5. 2 | et al analysed the 14 WHO worlds regions but for our calculations,
9409 II, 5. 5. 3 | Miller, K.K, Almazan, C, Worley, M,. Soyka, L.A, Herzog,
9410 III, 10. 1. 1 | of anxiety, stress, and worries (Bondy, 1996; Pohorecky,
9411 II, 9. 2. 2 | is their state of health? Worryingly, neither of these questions
9412 II, 5. 6. 6 | Care 6:669-678~Linos A, Worthington JW, O'Fallon WM, Kurland
9413 III, 10. 2. 1 | group, they are essentially worthless. Communication should be
9414 II, 9. 2. 2 | is usually not considered worthwhile or justified, and this appears
9415 II, 5. 11. 3 | bullous diseases, chronic wounds such as venous and decubitus
9416 II, 5. 5. 2 | Europe (2007): EuroCoDe, WP4 survey on social support
9417 II, 5. 9. FB | Associations~- The SCALE strategy~- WP5: Clustering of European
9418 II, 5. 5. 3 | Further validation of the WPSI vocational scale: comparisons
9419 III, 10. 2. 1 | and Statistics.~ ~James WPT, Jackson-Leach R, nì Mhurchu
9420 II, 5. 8. 7 | Schols AM, Postma DS, Pieters WR, Roldaan AC, Wouters EF (
9421 I, 2. 10. 4 | of patient identity via a wristband, enabling the introduction
9422 I, 2. 10. 4 | identification codes on wristbands.” 22~ ~
9423 II, 9. 4. 3 | many do not use condoms. Wrongly considered to be at low
9424 II, 5. 6. 6 | Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud
9425 III, 10. 4. 3 | catchment to consumer. WHO/SDE/WSH/05.06. Available at: htt ml~
9426 II, 9. 3. 3 | neighbouring countries). Helsinki:WSOY.~Haavio-Mannila E, Kontula
9427 III, 10. 4. 3 | supports the development of WSPs and is one of the drivers
9428 III, 10. 2. 1 | antropometryczne przeprowadzone wśród 4153 osób [Nutritional status
9429 III, 10. 4. 2 | al, 2004; Greenpeace and WWF, 2005). This gives special
9430 II, 9. 2. 7 | com/csi/eurosafe2006.nsf/wwwVwContent/l3childsafetyactionplanning.
9431 II, 9. 3. 3 | P, da Silva MO, Astin M, Wyness L, Bloemenkamp KWM, Jahn
9432 II, 5. 2. 3 | hospital discharge rates (x100.000) from all CVD, IHD,AMI,
9433 II, 7. 7 | and intentional self-harm (X60-X84). EU27, 3 year average of
9434 II, 7. 7 | inhabitants), Homicide, assault (X85-Y09). EU27, 3 year average of
9435 III, 10. 4. 2 | how a number of organica xenobiotic chemicals have been detected
9436 IV, 12. 10 | Protection with the code name “Xenokratis”, which among others determines
9437 IV, 12. 10 | 2. combating racism and xenophobia in relation to the labor
9438 IV, 12. 10 | Sozialgesetzbuch (Social Security Code XII) Social Welfare: §67, §68 [
9439 IV, 11. 6. 5 | of Economics Literature XL: 881-906.~ ~De Graeve D,
9440 II, 5. 14. 8 | www.cecdo.org/pages/EUEEA.xls (article online, accessed
9441 III, 10. 2. 1 | Body mass index in 7-9-y-old French children: frequency
9442 III, 10. 2. 1 | Chadjigeorgiou C, Kourides YA, Savva ME, Panagi A, Chrictodoulou
9443 II, 5. 7. 1 | Health Organization, 2005; Yach et al, 2004). However, it
9444 II, 5. 2. 7 | Daviglus ML, Liu K, Pirzada A, Yan LL, Garside DB, Greenland
9445 III, 10. 1. 3 | PM, Sallis JF, King AC, Yancey AK, Franklin BA, Buchner
9446 I, 2. 7 | China at the mouth of the Yangtze River. The 86 square km
9447 II, 5. 5. 3 | 40.~Lysaker PH, Tsai J, Yanos P, Roe D (2007): Associations
9448 II, 5. 6. 6 | Nielsen H, Silman A, Smolen J, Yazici H (2007): EULAR Recommendations
9449 | Ye
9450 III, 10. 2. 1 | Katz DL, O’Connell M, Yeh MC, Nawaz H, Njike V, Anderson
9451 III, 10. 4. 2 | Verotoxigenic Escherichia coli and Yersinosis ~Considerable~Unclear~Unclear~
9452 III, 10. 4. 2 | Czech Republic~Υπουργείου Υγείας της Κυπριακής Δημοκρατίας~
9453 IV, 11. 1. 3 | by the WHO in 2000, which yielded a ranking of health systems
9454 III, 10. 5. 1 | 539.~Norback D, Tao J, Mi YL, Ferm M, (2000) Current
9455 III, 10. 5. 1 | Palonen, J, Tuomisto, JT, Yli-Tuomi, T, Seppänen, O, Jantunen,
9456 II, 5. 5. 3 | Of Life With Disability~YLL~Years Of Life Lost~ ~ ~ ~
9457 II, 5. 5. 3 | mortality (years of life lost, YLLs) and of lifetime adjusted
9458 II, 5. 11. 3 | 4%,1-year prevalence=10%~Yngveson M, et al~ ~Danish school
9459 II, 7. 7 | N, Sethi D, Racioppi F, Yordi Aguirre I, Baumgarten I (
9460 III, 10. 4. 2 | Uno, A, Saijo, Y, Sata, F, Yoshimura, Y, Kishi, R, Nakazawa,
9461 II, 9. 3. 3 | Family Health International (YouthNet Program).~Klavs I, Rodrigues
9462 II, 5. 2. 7 | study [htt rg/doi:10.1016/j.ypmed.2008.01.023] (accessed on
9463 III, 10. 4. 2 | inspekce~Czech Republic~Υπουργείου Υγείας της Κυπριακής Δημοκρατίας~
9464 II, 5. 9. 4 | clinical asthma among 13- to 14-yr-old adolescents seem to be significantly
9465 II, 5. 9. FB | allergic diseases at 18 – 47 ys of age (Bener et al, 2007).
9466 III, 10. 2. 1 | Bueno-de-Mesquita HB, van der Schouw YT, Engeset D, Skeie G, Tormo
9467 III, 10. 2. 5 | former Federal Republic of Yugoslavia, and it provides the only
9468 II, 5. 5. 3 | Psychiatry 75;711-716.~Tola MA, Yugueros MI, Fernández-Buey N, Fernández-Herranz
9469 II, 5. 5. 3 | 1791.~Rutter M, Graham P, Yule W (1970): A neuropsychiatric
9470 -, 1 | Committee (Peter Achterberg, Yves Charpak, Pietro Folino Gallo,
9471 III, 10. 4. 2 | správa~Slovakia~Direktorat za varno hrano~Slovenia~Agencia
9472 III, 10. 3. 4 | Rousse, Velico Tarnovo, Stara Zagora, Haskovo, Pazardzik, Shoumen
9473 II, 4. 3 | Policies. B. Marin and A. Zaidi. Aldershot - Brookfield
9474 III, 10. 2. 1 | Rodler I, Bíró L, Greiner F, Zajkás G, Szórád I, Varga A, Domonkos
9475 II, 5. 12. 7 | Corrao G, Ferrari P, Zambon A, Torchio P, Arico S, Decarli
9476 II, 5. 7. 7 | Laurenzi M, Mancini M, Zanchetti A, Lombardi C, De Santo
9477 II, 5. 3. 2 | Registry roles and functions (Zanetti and Primic-Zakelj, 2007)~ ~
9478 III, 10. 5. 1 | Garber, 2007; Rogers and Zaragoza, 2003). In addition, green
9479 III, 10. 5. 1 | 3): 328-339~Rogers MAM, Zaragoza-Lao E: Happiness and children’
9480 III, 10. 2. 1 | Veronesi U, Wald N, Weber W, Zaridze DG, Zatonski W, zur Hausen
9481 II, 5. 5. 3 | Heeringa S, Pennell BE, Zaslavsky AM, Ustun TB, Chatterji
9482 II, 5. 7. 7 | FT, Nieuwenhuizen MG, de ZD, et al (2004): Trends in
9483 III, 10. 4. 2 | Monitoring~ ~WHO, 1996~Zearalenone~ ~Maize, wheat~Oestrogenic
9484 III, 10. 5. 2 | Presentation held by Jouke van der Zee et al. (Netherlands Institute
9485 III, 10. 3. 1 | B (2006) Prüss-Üstün A, Zeeb H, Mathers C, RepacholiM (
9486 III, 10. 4. 2 | Forestry~Bulgaria~Státní zemìdìlské a potravináøské inspekce~
9487 III, 10. 2. 1 | 242-247.~ ~Luo J, Ye W, Zendehdel K, Adami J, Adami H-O, Bofetta
9488 II, 5. 7. 7 | 1296-305.~Gorodetskaya I, Zenios S, McCulloch CE, Bostrom
9489 II, 5. 8. 7 | Jakobsson P, Molstad S, Zetterstrom O. (2004): Early detection
9490 II, 5. 8. 7 | Ko FW, Liu SM, Zheng JP, Zhong NS, Ip MS, Vermeire PA.
9491 II, 9. 3. 3 | Beltzer N, Lagarde M, Wu Zhou X, Vongmany N, Gremy I (
9492 III, 10. 2. 1 | Steinberg MB, Williams JM, Ziedonis DM (2006): Developments
9493 II, 5. 5. 3 | Moutard-Martin F, Dujardin M, Ziegler M (1999): Cost of illness
9494 II, 5. 6. 6 | Een Nationale Studie Naar Ziekten en Verrichtingen in de Huisartspraktijk.
9495 III, 10. 2. 1 | Villeruša A, Dzērve V, Zīle S, Helasoja V, Paalanen
9496 II, 6. 3. 7 | traveller returning from Zimbabwe. No cases were reported
9497 III, 10. 2. 1 | 4: 537-545.~ ~Kraemer K, Zimmermann MB (ed.). Nutritional anaemia.
9498 III, 10. 2. 4 | A, Schröder P, Brand H, Zimmern R (2006): Getting Ready
9499 II, 5. 7. 7 | Dunstan DW, Welborn TA, Zimmet PZ, et al (2003): Prevalence
9500 II, 5. 15. 6 | Israeli A, Chertkoff R, Zimran A (2006): National health
9501 III, 10. 3. 2 | Triutylzinn (TBT) und andere zinnorganische Verbindungen in Lebensmitteln
9502 III, 10. 3. 2 | B Bocca, P Schramel, M Zischka, C Pettersson, U Wass, M
9503 IV, 12. 10 | Protection Act (Gesetz zum zivilrechtlichen Schutz vor Gewalttaten und
9504 II, 5. 5. 3 | 13(3):406-413.~Clarke CE, Zobkiw RM, Gullaksen E (1995):
9505 II, 5. 6. 6 | Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological
